Pin to quick picksSareum Regulatory News (SAR)

Share Price Information for Sareum (SAR)

London Stock Exchange
Share Price: 0.345
Bid: 0.33
Ask: 0.36
Change: 0.00 (0.00%)
Spread: 0.03 (9.09%)
Open: 0.36
High: 0.36
Low: 0.345
Yest. Close: 0.36
SAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.
12
Date   Source Headline
16th Aug 20197:00 amRNSSareum Holdings PLC - Change of Adviser
8th Aug 20192:17 pmRNSSareum Holdings PLC - Sareum notes Sierra Q2 results
29th Jul 20194:29 pmRNSSareum Holdings PLC - Additional disclosure concerning Michael Owen
28th Jun 20197:00 amRNSSareum Holdings PLC - Additional Funds Raised
27th Jun 20191:50 pmRNSSareum Holdings PLC - Sierra seeks strategic options for SRA737
26th Jun 20197:00 amRNSSareum Holdings PLC - Successful Fundraising
25th Jun 20194:31 pmRNSSareum Holdings PLC - PrimaryBid.com Offer
25th Jun 20194:30 pmRNSSareum Holdings PLC - Placing to progress TYK2/JAK1 programmes
13th Jun 20197:00 amRNSSareum Holdings PLC - Portfolio Update
3rd Jun 20194:00 pmRNSSareum Holdings PLC - Key takeaways from SRA737 webcast at ASCO
3rd Jun 201911:05 amRNSSareum Holdings PLC - Second Price Monitoring Extn
3rd Jun 201911:00 amRNSSareum Holdings PLC - Price Monitoring Extension
3rd Jun 20197:00 amRNSSareum Holdings PLC - Positive SRA737 data presented at ASCO
16th May 20197:00 amRNSSareum Holdings PLC - ASCO abstracts for SRA737 published
8th May 201912:41 pmRNSSareum Holdings PLC - Sareum notes Sierra Oncology Q1 2019 Results
30th Apr 20197:00 amRNSSareum Holdings PLC - Sareum to Present at BioTrinity 2019 in London
23rd Apr 20197:00 amRNSSareum Holdings PLC - SRA737 Phase I/IIa data to be presented at ASCO
2nd Apr 20197:00 amRNSSareum Holdings PLC - Preclinical Data for SRA737 Presented at AACR 2019
12th Mar 20197:00 amRNSSareum Holdings PLC - Sareum Holdings PLC Issue of Options
4th Mar 20197:00 amRNSSareum Holdings PLC - HALF-YEARLY RESULTS ENDED 31 DECEMBER 2018
28th Feb 20192:04 pmRNSSareum Holdings PLC - Sierra Oncology has reported its 2018 Results
28th Feb 20198:14 amRNSSareum Holdings PLC - New SRA737 preclin data to be presented at AACR
23rd Jan 20191:38 pmRNSSareum Holdings PLC - Sierra Oncology to present SRA737 at DDR Tx Summit
30th Nov 201811:17 amRNSSareum Holdings PLC - Amendment to Preclinical Efficacy Announcement
30th Nov 20187:45 amRNSSareum Holdings PLC - Preclinical Efficacy for Immunotherapy Combination
1st Oct 20187:00 amRNSSareum Holdings PLC - FINAL RESULTS FOR THE YEAR ENDED 30 JUNE 2018
27th Sep 20181:03 pmRNSSareum Holdings PLC - Notice of Results
26th Sep 20187:00 amRNSSareum Holdings PLC - TYK2/JAK1 selected for certain cancers
11th Sep 20187:00 amRNSSareum Holdings PLC - Pre-Close Trading Statement
10th Sep 20187:00 amRNSSareum Holdings PLC - Selection of TYK2/JAK1 for autoimmune diseases
9th Aug 20181:15 pmRNSSareum Holdings PLC - Sareum notes Sierra Oncology Q2 2018 Results
15th Jun 20187:00 amRNSSareum Holdings PLC - Advisers
31st May 20187:00 amRNSSareum Holdings PLC - Sareum regains rights to Aurora+FLT3 inhibitors
10th May 201812:21 pmRNSSareum Holdings PLC - SRA737 trial update in Sierra Oncology Q1 Results
15th Mar 20187:00 amRNSSareum Holdings PLC - Late-breaker abstract for SRA737 accepted for AACR
27th Feb 201812:50 pmRNSSierra Oncology expands SRA737 development program
22nd Feb 20187:00 amRNSPreclinical synergy of sra737 and PARP inhibitor
14th Dec 20177:00 amRNSAGM Statement
20th Nov 20177:00 amRNSNotice of AGM and Annual Report & Accounts
18th Sep 201712:00 pmRNSSierra Oncology to host call on Chk1 inhibitor
31st May 20177:00 amRNSSierra Oncology Granted US and EU Patents
25th May 20177:00 amRNSSierra Oncology to Present at ASCO Annual Meeting
9th Feb 20177:00 amRNSNotice of Interim Results
22nd Dec 20169:47 amRNSResult of General Meeting
15th Dec 201611:38 amRNSResult of AGM
24th Oct 20167:00 amRNSSuccessful Outcome from TYK2 Feasibility Study
27th Sep 201612:02 pmRNSLicence agreement for Chk1 Inhibitor CCT245737
23rd May 201612:00 pmRNSClinical Trials CHK1 Inhibitor CCT245737 to Open
5th Apr 201610:38 amRNSCHK1 Approved for Clinical Trials
24th Mar 201611:54 amRNSPlacing
12

Login to your account

Don't have an account? Click here to register.